A 10-year-old boy had a sudden onset, uh, stomach pain followed by drowsiness and, uh, weakness of all four limbs, was, uh, taken to the outside hospital, given Biscopan, Rizofar, and, uh, Pantop. He became more drowsy, so was brought to hospital. When he was brought to the hospital, initially he have quadriplegia with, uh, drowsiness and breathing difficulty. So he was, uh, started on, uh, because he, because he lives in a field, he was started on ASV, suspect of some snake bite or something, and Neostigmine every third hourly. After Neo- and some antibiotics. Uh, after Neostigmine, uh, and this ASV, patient showed mild improvement. Uh, now he became conscious and, uh, he, at present, he have bilateral ptosis. EOM is restricted. Uh, mild, uh, facial, uh, sneer face. It's kind of sneer face, he said. And, uh, single breath count is five. Hand holding up to two and a half minutes, and legs, uh, he was able to hold for 10 seconds. Uh, so he was, uh, underwent investigations. Uh, blood counts, everything, RFT, LFT, everything was normal. NCS was normal, but, uh, RNS, a doubtful decrement, not, uh, clear-cut. And, uh, EEG is showing multiple interictal discharges.
neurotoxic snakebite children neostigmine treatment
snakebite neurotoxicity neostigmine atropine
cobra snakebite neuromuscular junction children treatment
neurotoxic snakebite cobra child quadriplegia ptosis neostigmine ASV treatment India
| Feature | Present in This Patient |
|---|---|
| Acute onset abdominal pain + flaccid quadriplegia | Yes |
| Bilateral ptosis | Yes |
| Restricted extraocular movements | Yes |
| Facial weakness ("sneer face") | Yes |
| Respiratory compromise (SBC = 5) | Yes |
| Drowsiness/altered consciousness | Yes |
| Rural/field setting | Yes |
| Partial response to neostigmine | Yes |
| Doubtful decrement on RNS | Yes |
| EEG - interictal discharges | Yes |
| Normal NCS, CBC, RFT, LFT | Yes |
| Feature | Cobra (Naja naja) | Common Krait (Bungarus caeruleus) |
|---|---|---|
| Mechanism | Postsynaptic alpha-neurotoxin - blocks AChR | Presynaptic - blocks ACh release |
| Neostigmine response | Yes - effective (competes with toxin at AChR) | Poor/no response |
| ASV response | Good | Moderate |
| Time of bite | Daytime often | Typically nocturnal |
| Abdominal pain | Can occur | Less common |
| "Mild improvement" with neostigmine | Consistent with cobra | Would not improve |
| Rank | Diagnosis | For | Against |
|---|---|---|---|
| 1 | Cobra envenomation | Field setting, acute onset, postsynaptic NMJ block, neostigmine response, facial weakness | No visible bite mark (often the case!) |
| 2 | Krait envenomation | Rural, nocturnal child asleep on floor | Neostigmine partial response (krait doesn't respond), presynaptic block |
| 3 | Botulism | Descending paralysis, ptosis, EOM, facial weakness, RNS findings | No food exposure history, acute onset over hours, alert consciousness not typical, response to neostigmine in botulism is variable |
| 4 | Myasthenic crisis (juvenile MG) | Ptosis, EOM restriction, fatigable weakness, decrement on RNS | New-onset in acute rural setting less likely, no prior history, though cannot exclude |
| 5 | GBS (Miller Fisher variant) | Ophthalmoplegia, ataxia, areflexia | NCS normal, no albuminocytologic dissociation mentioned, quadriplegia more than typical MFS |
I am not able to understand why interictal discharges are present in the EEG.
snakebite EEG seizure encephalopathy children
snakebite neurotoxin CNS direct brain effects venom
hypoxia interictal epileptiform discharge EEG mechanism
neurotoxic snakebite cobra EEG interictal discharges seizure mechanism hypoxia venom CNS
Cobra neurotoxin
↓
NMJ blockade → respiratory muscle paralysis
↓
Hypoventilation → hypoxia + hypercapnia
↓
Cerebral hypoxia
↓
Preferential injury to inhibitory interneurons (GABAergic neurons are
MORE vulnerable to hypoxia than excitatory neurons)
↓
Loss of inhibitory tone → unopposed cortical excitability
↓
Interictal epileptiform discharges on EEG
| Toxin Component | Central Action |
|---|---|
| Alpha-cobratoxin (3FTX) | Binds neuronal alpha-7 nicotinic ACh receptors (nAChRs) in the brain (hippocampus, cortex) |
| Phospholipase A2 (PLA2) | Disrupts neuronal membranes and synaptic vesicle release centrally |
| Dendrotoxins (mambas, but illustrative) | Produce EEG discharges and electrocortical convulsions in animal studies |
| Waglerin-1 | Inhibits GABAergic transmission centrally |
Cobra bite → NMJ block → respiratory failure → Cerebral hypoxia
↓
Direct venom effect on ↓ Coincidental epileptic
neuronal alpha-7 nAChRs → ↓ ← predisposition?
↓
INTERICTAL DISCHARGES
(hypoxic disinhibition
is the dominant driver)
매니지먼트. 어, 시니로톡신.
neurotoxic snakebite management protocol ASV neostigmine atropine ventilation India guidelines 2024
Given English and why this case is not myasthenia? Why it is neurotoxin? Give me clearly what, why?
| Feature | This Patient | Myasthenia Gravis | Neurotoxic Envenomation (Cobra) |
|---|---|---|---|
| Age / setting | 10-yr-old, field/rural | Any age, no geographic link | Rural field - classic |
| Onset | Sudden - hours | Subacute - weeks to months | Sudden - hours after bite |
| Preceding symptom | Abdominal pain first | Never starts with abdominal pain | Abdominal pain is classic in cobra bite |
| Progression | Rapid - straight to quadriplegia + respiratory failure | Gradual, fluctuating, fatigable | Rapid descending paralysis |
| Fatigability | NOT described - weakness is constant and profound | YES - hallmark. Worse with activity, better with rest | NOT fatigable - fixed paralysis |
| Level of consciousness | Drowsy on arrival | Always fully conscious | Drowsiness from hypoxia/CNS toxin |
| Facial weakness | Yes - "sneer face" | Mild, if present | Yes - CN VII palsy |
| Respiratory failure | Present - SBC = 5 | Only in crisis (rare, chronic disease) | Directly caused by NMJ block |
| NCS | Normal | Normal | Normal |
| RNS decrement | Doubtful/mild | Clear decrement >10-15% at 3 Hz | May show decrement, often partial/subtle |
| AChR antibodies | Not checked yet | Positive in 85% generalized MG | Negative |
| Response to neostigmine | Mild improvement | Dramatic improvement | Partial improvement (postsynaptic cobra) or none (krait) |
| Prior history | None | Usually has prior episodes, fluctuating course | None - first-ever event |
| Test | MG result | Envenomation result |
|---|---|---|
| AChR antibody | Positive (85%) | Negative |
| Anti-MuSK antibody | Positive (in seronegative MG, ~40%) | Negative |
| CT Chest | May show thymoma | Normal |
| Edrophonium/Tensilon test | Dramatic full reversal | Partial reversal only |
| RNS after stopping neostigmine 12h | Clear >10% decrement returns | May normalize as venom clears |
| Venom detection assay | Negative | Positive (if available) |
| Clinical course | Chronic, fluctuating, recurs | Resolves over days-weeks as venom is cleared/neutralized |
Snake bite management
WHO India snakebite management guidelines 2024 neurotoxic hemotoxic ASV protocol
| Type | Snake | Key Features |
|---|---|---|
| Neurotoxic | Cobra, Krait | Ptosis, EOM palsy, facial weakness, descending paralysis, respiratory failure |
| Hemotoxic / Vasculotoxic | Russell's Viper, Saw-scaled Viper | Bleeding, coagulopathy, DIC, local necrosis, AKI |
| Mixed | Russell's Viper (can have neurotoxic features too) | Both above |
| Dry bite | Any | No envenomation signs - observe 24h |
| Step | Action |
|---|---|
| Pre-medicate | Adrenaline 0.25 mg SC (adults) / 0.01 mg/kg SC (children) - reduces anaphylaxis risk. Add hydrocortisone + antihistamine |
| Route | IV infusion only - dilute in 100 ml normal saline |
| Rate | Infuse over 30-60 minutes (slow infusion, not bolus) |
| Do NOT give IM | Unpredictable absorption, painful |
| Envenomation | Initial dose | Notes |
|---|---|---|
| Neurotoxic | 10 vials stat | Repeat 10 vials after 1-2h if no improvement or worsening. Max 20 vials total |
| Hemotoxic (mild) | 8-10 vials stat | Repeat 6-hourly if 20WBCT still non-clotting. Max ~30 vials |
| Children | Same dose as adults | Children receive the same number of vials - the dose neutralizes venom quantity, not body weight |
| King cobra / Australian elapids | 50+ vials | These inject massive venom volumes |
Critical rule: Once 20 vials given for neurotoxic (or patient on ventilator), STOP ASV - all circulating venom is neutralized. Further improvement depends on supportive care.
| Reaction | Time | Treatment |
|---|---|---|
| Anaphylaxis (urticaria, bronchospasm, hypotension) | Within 10-180 min | Stop ASV, adrenaline 0.5 mg IM, antihistamine, hydrocortisone, restart ASV slowly once stable |
| Serum sickness (fever, rash, arthralgia, lymphadenopathy) | 5-10 days later | Oral prednisolone 5 mg 6-hourly for 5 days |
| Dose | Drug | Adult | Child |
|---|---|---|---|
| Loading (stat) | Atropine FIRST | 0.6 mg IV | 0.05 mg/kg IV |
| Then | Neostigmine | 1.5 mg IV | 0.04 mg/kg IV |
| Repeat every 30 min x5 | Neostigmine + Atropine | 0.5 mg + 0.6 mg IV | 0.01 mg/kg each |
| Taper | Then at 1h, 2h, 6h, 12h | Reduce dose | Reduce dose |
Note on glycopyrrolate: Can be used instead of atropine - does not cross blood-brain barrier, so avoids central cholinergic side effects.
| Bedside Test | Trigger for Intubation |
|---|---|
| Single Breath Count (SBC) | <10 (normal ~20-25) |
| Neck lift test | Cannot lift head from bed |
| Hand hold | <2 minutes |
| Tidal volume | <200 ml |
| SpO2 | Falling despite O2 |
| Clinical | Pooling secretions, bulbar palsy |
This patient (SBC = 5) is at immediate risk - elective intubation is safer than emergency intubation during apnea.
| Problem | Management |
|---|---|
| Coagulopathy / DIC | ASV (stops venom production of coagulopathy) - FFP if active bleeding |
| Thrombocytopenia + bleeding | Platelet transfusion |
| Local necrosis / cellulitis | Wound care, antibiotics (Amoxicillin-Clavulanate or Cephalexin) |
| Compartment syndrome | Fasciotomy only if confirmed (measure compartment pressure >40 mmHg); NOT just for swelling |
| Acute Kidney Injury | IV fluids, monitor urine output, dialysis if needed |
| Hypotension / shock | IV fluids, vasopressors if unresponsive |
| Parameter | Frequency |
|---|---|
| Vitals, SpO2, neurological assessment | Every 30-60 minutes (first 6 hours) |
| SBC and neck lift | Every 1-2 hours in neurotoxic bites |
| 20WBCT | Every 6 hours in hemotoxic bites |
| Urine output | Hourly (target >0.5 ml/kg/hr) |
| Swelling margin | Every 30 min (mark and time) |
NEUROTOXIC HEMOTOXIC
Cobra / Krait Russell's Viper / Saw-scaled
ASV 10 vials + repeat ASV 8-10 vials + 6-hourly
AN protocol (cobra only) Monitor 20WBCT every 6h
Monitor SBC / neck lift Monitor urine output / creatinine
Intubate early (SBC <10) FFP if active bleeding
Ventilate if needed Dialysis if AKI
Yes
Apply management protocol step-by-step to this 10yo boy's case
| What happened | What should have happened |
|---|---|
| Taken to outside hospital | ✔ Correct — seek care immediately |
| Given Buscopan, Rizofar, Pantop (treated as gastroenteritis) | ✗ Wrong — abdominal pain in a rural child with subsequent paralysis = snakebite until proven otherwise |
| Became more drowsy → referred | Referral was delayed — should have been referred the moment quadriplegia appeared |
| No mention of limb immobilization or pressure bandage | ✗ Missed — should have had pressure immobilization bandage on the bitten limb during transport |
Lesson: The single most dangerous pre-hospital error here was misdiagnosis as gastroenteritis. Abdominal pain + rural setting + child = always think snakebite.
| Test | Expected finding in this child | Why |
|---|---|---|
| 20WBCT | Likely normal (no bleeding, normal CBC/LFT) | Rules out hemotoxic envenomation — this is pure neurotoxic |
| Single Breath Count | 5 (documented) | Critically low — severe respiratory compromise |
| Neck lift test | Almost certainly failed | If SBC is 5, neck muscles are equally weak |
| Ptosis check | Bilateral ptosis (documented) | Confirms NMJ involvement at cranial nerve level |
| EOM assessment | Restricted (documented) | CN III/IV/VI involved |
| Pupil exam | Should be checked — mydriasis suggests autonomic involvement | |
| SpO2 | Likely low — not documented but implied by breathing difficulty |
| Parameter | Protocol says | Applied to this child |
|---|---|---|
| Initial dose | 10 vials IV infusion | 10 vials in 100 ml NS over 30-60 min ✔ |
| Pre-medication | Adrenaline 0.01 mg/kg SC | 0.3 mg adrenaline SC before infusion |
| Route | IV infusion only | NOT IM, NOT bolus |
| Children's dose | Same as adults (10 vials) | Same — venom quantity, not body weight |
| Reassess at 1-2h | If no improvement → repeat 10 vials | If still deteriorating at 2h → second dose |
| Maximum | 20 vials for neurotoxic | After 20 vials — all circulating venom neutralized; move to supportive care |
| Timing | Drug | Dose (child: ~32 kg) |
|---|---|---|
| Stat — FIRST | Atropine IV | 0.05 mg/kg = 1.6 mg IV |
| Immediately after | Neostigmine IV | 0.04 mg/kg = 1.28 mg IV |
| +30 min | Neostigmine + Atropine | 0.01 mg/kg neostigmine = 0.32 mg + atropine 0.6 mg IV |
| +60 min | Repeat | Same as above |
| +90 min | Repeat | Same |
| +120 min | Repeat | Same (5th dose) |
| Taper | Then at 1h, 2h, 6h, 12h intervals | Reducing frequency |
Critical error in this case: Every-3-hourly dosing means the child spent 2.5 hours with inadequate ACh competition at the AChR between doses — the cobra toxin maintained its grip, causing continued respiratory compromise and persistent ptosis.
| Bedside test | This child's result | Interpretation |
|---|---|---|
| Single Breath Count | 5 | Critically low (normal = 20-25) |
| Hand hold | 2.5 minutes | Borderline (normal ~3-5 min) |
| Leg hold | 10 seconds | Significantly reduced |
| Bilateral ptosis + restricted EOM | Present | Bulbar muscles involved |
| Breathing difficulty | Present | Diaphragm and accessory muscles affected |
This child needs elective intubation NOW.
| Action | Rationale |
|---|---|
| Fix hypoxia first (intubate, ventilate) | Removes the primary driver of cortical irritability |
| Continuous SpO2 monitoring | Maintain SpO2 >95% at all times |
| EEG monitoring if available | Watch for progression to status epilepticus |
| Do NOT start antiepileptics routinely yet | Discharges are likely situational (hypoxic) |
| If clinical seizures occur → Levetiracetam | 20 mg/kg IV loading dose — minimal respiratory depression, safe in this context |
| Avoid benzodiazepines as first-line AED | Further respiratory depression in an already compromised child |
| Repeat EEG at 4-6 weeks post-recovery | If discharges persist → true epilepsy → manage accordingly |
| Parameter | Frequency | Target |
|---|---|---|
| SpO2, RR, HR, BP | Every 30 min | SpO2 >95% |
| SBC + neck lift | Every 1-2 hours | SBC trending up |
| Ptosis assessment | Every 30 min (with AN doses) | Improving |
| Pupil size and reactivity | Every 2 hours | Monitor for autonomic dysfunction |
| Urine output | Hourly | >0.5 ml/kg/hr (~15-17 ml/hr) |
| 20WBCT | At admission, 6h | Should remain normal (neurotoxic bite) |
| Renal function | Daily | Baseline normal — monitor |
| Serum electrolytes | Daily | Especially K⁺ (risk with neostigmine) |
| Drug | Reason to avoid |
|---|---|
| Succinylcholine (if intubating) | Hyperkalemia risk |
| Sedatives / opioids | Worsen respiratory depression |
| NSAIDs | Not indicated; avoid in envenomation |
| High-dose benzodiazepines | Worsen respiratory failure |
| Continuing neostigmine every 3h | Subtherapeutic — too infrequent |
| Timeline | Expected progress |
|---|---|
| 0-6 hours | ASV + corrected AN → stabilization, partial ptosis improvement |
| 6-24 hours | If cobra: gradual improvement in SBC, ptosis; continue AN tapering |
| 24-48 hours | Weaning from ventilator if SBC >15, neck lift positive |
| 48-72 hours | Extubation if criteria met; continue oral pyridostigmine if needed |
| 5-7 days | Full recovery expected for cobra bite |
| If krait bite | May need 1-3 weeks of ventilation — presynaptic block reverses only with nerve terminal regeneration |
| 4-6 weeks | Repeat EEG to assess interictal discharges |
DONE ✔ NEEDS CORRECTION / ADDITION ✗
───────────────────────────── ─────────────────────────────────────────
ASV started → Ensure 2nd dose given if no improvement at 2h
Neostigmine started → CHANGE to every 30 min (not 3-hourly)
Antibiotics given → Appropriate, continue
Patient conscious now → Do not be reassured — SBC=5 is still critical
URGENT ADDITIONS:
→ INTUBATE ELECTIVELY NOW (SBC=5)
→ Atropine BEFORE every neostigmine dose
→ Continuous SpO2 monitoring
→ Levetiracetam ready if seizures occur
→ Repeat EEG at recovery